Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Lymphoma is a malignant tumor of the lymphatic system, mainly classified into Hodgkin lymphoma and non-Hodgkin lymphoma. It is caused by abnormal proliferation of immune cells, which severely impacts immune function. Lymphoma can occur in any part of the body containing lymphatic tissue, including lymph nodes, spleen, and bone marrow, and has invasive and metastatic potential.
The incidence of lymphoma is increasing globally, with higher rates in North America and Europe. In East and Southeast Asian countries such as China and India, the incidence has also been rising in recent years. The disease affects all age groups, but is more common in middle-aged and elderly individuals, posing a significant public health challenge.
1. Lymph Node Enlargement and Compression Symptoms
The most typical manifestation of lymphoma is painless lymph node enlargement. If the mass compresses adjacent organs, it may cause breathing difficulties, swallowing problems, and other symptoms, severely affecting quality of life.
2. Decline in Immune Function
Lymphoma damages normal immune cell function, leading to reduced resistance, frequent secondary infections, and increased mortality risk.
3. Significant Systemic Symptoms
Patients often present with fever, night sweats, and weight loss, known as "B symptoms," which indicate high disease activity and poor prognosis.
Immune reconstitution cell therapy enhances the patient’s own immune system to fight tumors, promotes lymphoma cell clearance, and effectively reduces the risk of recurrence.
In clinical practice, tumor patients undergoing surgery, radiotherapy, or chemotherapy often face immune function impairment, increased infection risk, and delayed recovery. To better support the treatment process, improve tolerance, and enhance survival quality, phased immune reconstitution plans are needed for different treatment stages.
● Short-term plan: Rapidly improve immunity through immune cell reinfusion to enhance the effectiveness of antitumor therapy.
● Mid-term plan: Reduce side effects of traditional treatments, promote recovery, and help complete standardized treatment regimens.
● Long-term plan: Comprehensive immune enhancement through immune cell reconstruction, gut immune reconstitution, elemental immune restoration, and immune nutrition rebuilding, to improve quality of life and extend survival.
1. Chemotherapy
Chemotherapy is the foundation of lymphoma treatment, using drugs to kill rapidly proliferating tumor cells, often combined with radiotherapy to improve cure rates.
2. Radiotherapy
Local radiotherapy controls localized lymphoma lesions, relieves symptoms, and reduces tumor burden, suitable for early and localized cases.
3. Targeted Therapy
Targeted therapy drugs act on specific molecular targets in lymphoma cells, allowing precise elimination of tumor cells with fewer side effects compared to chemotherapy and showing significant efficacy.
4. Minimally Invasive Treatments
Minimally invasive techniques such as radiofrequency ablation destroy tumor cells through local heating, causing less trauma and faster recovery, suitable for some localized lymphoma patients.
Lymphoma is a complex malignant tumor that can seriously endanger patient health if not diagnosed and treated promptly. Scientific and rational treatment strategies, especially the application of immune reconstitution cell therapy, bring new hope to patients. Experts at United Life International Medical Center emphasize the importance of early detection and multidisciplinary comprehensive treatment.
